News and Views
Nature Neuroscience 11, 124 - 126 (2008)
doi:10.1038/nn0208-124
Why endocannabinoids are not all alike
Vincenzo Di Marzo1 & Luigia Cristino1
- Vincenzo Di Marzo is at the Endocannabinoid Research Group, Istituto di Chimica Biomolecolare and Luigia Cristino is at the Istituto di Cibernetica, Consiglio Nazionale delle Ricerche, Via Campi Flegrei 34, Comprensorio Olivetti, 80078, Pozzuoli (NA), Italy. e-mail: vdimarzo@icmib.na.cnr.it
Abstract
New work in this issue shows that one principal endocannabinoid, anandamide, directly inhibits the synthesis of another, 2-arachidonoylglycerol. This finding could explain a number of puzzling observations in the endocannabinoid field.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Tyrosine-dependent increase of tyrosine hydroxylase in neuroblastoma cellsNature Letters to Editor (20 Dec 1974)
Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatumNature Neuroscience Article (01 Feb 2008)
See all 5 matches for Research